Cormorant Asset Management, LP Diversified Active

CIK: 0001583977 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value ($000): $906,836 (100.0% shares, 0.0% debt)

Holdings (84)

ALDER BIOPHARMACEUTICALS INC 6.1%
Value ($000) $55,351 Shares 1,689,071 Est. Cost $32.02 Unrealized
NEVRO CORP 5.7%
Value ($000) $51,260 Shares 491,044 Est. Cost $53.99 Unrealized
TBPH THERAVANCE BIOPHARMA INC 4.5%
Value ($000) $40,530 Shares 1,118,372 Est. Cost $21.59 Unrealized +28.9%
MINERVA NEUROSCIENCES INC 4.4%
Value ($000) $39,522 Shares 2,800,000 Est. Cost $7.26 Unrealized
PROTEOSTASIS THERAPEUTICS IN 4.0%
Value ($000) $36,636 Shares 2,350,000 Est. Cost $12.16 Unrealized
CLEARSIDE BIOMEDICAL INC 3.8%
Value ($000) $34,496 Shares 1,988,208 Est. Cost $7.01 Unrealized
EGRX EAGLE PHARMACEUTICALS INC 3.5%
Value ($000) $31,920 Shares 455,995 Est. Cost $40.56 Unrealized +36.6%
HRTX HERON THERAPEUTICS INC 3.4%
Value ($000) $30,519 Shares 1,771,263 Est. Cost $15.73 Unrealized +18.0%
ARDX ARDELYX INC 3.0%
Value ($000) $26,811 Shares 2,071,964 Est. Cost $15.57 Unrealized -32.7%
MYOKARDIA INC 2.9%
Value ($000) $26,239 Shares 1,605,790 Est. Cost $15.55 Unrealized
CLOVIS ONCOLOGY INC 2.6%
Value ($000) $23,433 Shares 650,000 Est. Cost $36.05 Unrealized
ACRS ACLARIS THERAPEUTICS INC 2.5%
Value ($000) $23,082 Shares 901,286 Est. Cost $19.47 Unrealized +8.9%
QUOTIENT LTD 2.4%
Value ($000) $21,800 Shares 2,787,717 Est. Cost $11.34 Unrealized
GLPG GALAPAGOS NV 2.4%
Value ($000) $21,441 Shares 334,044 Est. Cost $54.92 Unrealized
MGNX MACROGENICS INC 2.3%
Value ($000) $21,176 Shares 707,978 Est. Cost $27.09 Unrealized +9.8%
NBIX NEUROCRINE BIOSCIENCES INC 2.2%
Value ($000) $20,170 Shares 398,301 Est. Cost $15.30 Unrealized +225.6%
OMER OMEROS CORP 2.1%
Value ($000) $18,916 Shares 1,695,000 Est. Cost $15.02 Unrealized -24.1%
PTGX PROTAGONIST THERAPEUTICS INC 1.9%
Value ($000) $16,904 Shares 800,000 Est. Cost $13.67 Unrealized 0.0%
WVE WAVE LIFE SCIENCES LTD 1.8%
Value ($000) $16,492 Shares 507,907 Est. Cost $17.46 Unrealized +35.4%
SRNE SORRENTO THERAPEUTICS INC 1.8%
Value ($000) $16,417 Shares 2,121,013 Est. Cost $9.12 Unrealized -26.2%
CHRS COHERUS BIOSCIENCES INC 1.7%
Value ($000) $15,428 Shares 576,106 Est. Cost $20.95 Unrealized +30.2%
CHINA BIOLOGIC PRODS INC 1.5%
Value ($000) $14,050 Shares 112,867 Est. Cost $67.14 Unrealized
CORBUS PHARMACEUTICALS HLDGS 1.5%
Value ($000) $13,580 Shares 2,000,000 Est. Cost $2.99 Unrealized
PORTOLA PHARMACEUTICALS INC 1.5%
Value ($000) $13,535 Shares 596,000 Est. Cost $24.54 Unrealized
CLLS CELLECTIS S A 1.3%
Value ($000) $11,995 Shares 498,117 Est. Cost $30.85 Unrealized
AGENUS INC 1.2%
Value ($000) $11,331 Shares 1,578,106 Est. Cost $4.53 Unrealized
INVUITY INC 1.2%
Value ($000) $10,530 Shares 767,466 Est. Cost $13.53 Unrealized
ADVAXIS INC 1.1%
Value ($000) $9,845 Shares 920,915 Est. Cost $7.66 Unrealized
GEMPHIRE THERAPEUTICS INC 1.1%
Value ($000) $9,828 Shares 900,000 Est. Cost $10.92 Unrealized
CONTRAFECT CORP 1.1%
Value ($000) $9,526 Shares 3,840,966 Est. Cost $2.80 Unrealized
INC RESH HLDGS INC 1.0%
Value ($000) $8,916 Shares 200,000 Est. Cost $38.13 Unrealized
BLUEPRINT MEDICINES CORP 1.0%
Value ($000) $8,876 Shares 298,870 Est. Cost $26.50 Unrealized
COLL COLLEGIUM PHARMACEUTICAL INC 1.0%
Value ($000) $8,773 Shares 455,515 Est. Cost $17.28 Unrealized -31.3%
DXCM DEXCOM INC 1.0%
Value ($000) $8,766 Shares 100,000 Est. Cost $7.91 Unrealized +181.0%
ALNY ALNYLAM PHARMACEUTICALS INC 0.9%
Value ($000) $8,548 Shares 126,120 Est. Cost $108.02 Unrealized -34.7%
ACHILLION PHARMACEUTICALS 0.9%
Value ($000) $8,150 Shares 1,006,128 Est. Cost $9.29 Unrealized
AUDENTES THERAPEUTICS INC 0.9%
Value ($000) $8,008 Shares 449,660 Est. Cost $17.81 Unrealized
EBS EMERGENT BIOSOLUTIONS INC 0.9%
Value ($000) $7,883 Shares 250,000 Est. Cost $29.06 Unrealized 0.0%
RARE ULTRAGENYX PHARMACEUTICAL IN 0.9%
Value ($000) $7,863 Shares 110,842 Est. Cost $51.16 Unrealized +24.8%
ARRAY BIOPHARMA INC 0.9%
Value ($000) $7,763 Shares 1,150,000 Est. Cost $6.75 Unrealized
FLGT FULGENT GENETICS INC 0.8%
Value ($000) $7,376 Shares 800,000 Est. Cost $9.20 Unrealized 0.0%
FORWARD PHARMA A/S 0.8%
Value ($000) $7,123 Shares 339,175 Est. Cost $23.76 Unrealized
SGMO SANGAMO BIOSCIENCES INC 0.7%
Value ($000) $6,493 Shares 1,402,331 Est. Cost $6.37 Unrealized -20.2%
CURIS INC 0.7%
Value ($000) $6,292 Shares 2,410,900 Est. Cost $2.44 Unrealized
ZYNERBA PHARMACEUTICALS INC 0.7%
Value ($000) $6,271 Shares 480,501 Est. Cost $13.03 Unrealized
RECRO PHARMA INC 0.7%
Value ($000) $5,916 Shares 669,239 Est. Cost $7.16 Unrealized
CTMX CYTOMX THERAPEUTICS INC 0.6%
Value ($000) $5,827 Shares 371,636 Est. Cost $15.82 Unrealized -23.5%
DERMIRA INC 0.6%
Value ($000) $5,820 Shares 172,083 Est. Cost $18.24 Unrealized
PFENEX INC 0.6%
Value ($000) $5,661 Shares 632,559 Est. Cost $16.67 Unrealized
AVEXIS INC 0.6%
Value ($000) $5,434 Shares 131,858 Est. Cost $41.21 Unrealized
CATABASIS PHARMACEUTICALS IN 0.5%
Value ($000) $4,928 Shares 800,000 Est. Cost $6.16 Unrealized
INTEC PHARMA LTD JERUSALEM 0.5%
Value ($000) $4,762 Shares 809,804 Est. Cost $5.59 Unrealized
ACCELERON PHARMA INC 0.5%
Value ($000) $4,612 Shares 127,451 Est. Cost $32.04 Unrealized
ONCOBIOLOGICS INC 0.5%
Value ($000) $4,366 Shares 1,027,216 Est. Cost $3.40 Unrealized
RIGEL PHARMACEUTICALS INC 0.5%
Value ($000) $4,241 Shares 1,155,600 Est. Cost $3.67 Unrealized
LION BIOTECHNOLOGIES INC 0.5%
Value ($000) $4,164 Shares 505,941 Est. Cost $11.63 Unrealized
ATARA BIOTHERAPEUTICS INC 0.4%
Value ($000) $3,988 Shares 186,460 Est. Cost $35.41 Unrealized
AGILE THERAPEUTICS INC 0.4%
Value ($000) $3,936 Shares 563,880 Est. Cost $7.07 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.4%
Value ($000) $3,645 Shares 240,403 Est. Cost $12.61 Unrealized +4.3%
CRVS CORVUS PHARMACEUTICALS INC 0.4%
Value ($000) $3,522 Shares 214,132 Est. Cost $13.51 Unrealized +6.7%
LIPOCINE INC NEW 0.4%
Value ($000) $3,351 Shares 751,296 Est. Cost $6.47 Unrealized
IMMUNE DESIGN CORP 0.4%
Value ($000) $3,282 Shares 432,990 Est. Cost $12.79 Unrealized
APTOSE BIOSCIENCES INC 0.2%
Value ($000) $2,229 Shares 990,579 Est. Cost $5.91 Unrealized
RGNX REGENXBIO INC 0.2%
Value ($000) $2,196 Shares 156,741 Est. Cost $25.52 Unrealized -56.8%
GLYCOMIMETICS INC 0.2%
Value ($000) $2,052 Shares 287,031 Est. Cost $16.22 Unrealized
AQUINOX PHARMACEUTICALS INC 0.2%
Value ($000) $2,029 Shares 151,838 Est. Cost $12.08 Unrealized
CELYAD SA 0.2%
Value ($000) $1,791 Shares 75,920 Est. Cost $51.70 Unrealized
EPIZYME INC 0.2%
Value ($000) $1,570 Shares 159,513 Est. Cost $18.78 Unrealized
ASND ASCENDIS PHARMA A S 0.1%
Value ($000) $1,251 Shares 62,254 Est. Cost $17.30 Unrealized
FOLD AMICUS THERAPEUTICS INC 0.1%
Value ($000) $1,124 Shares 151,838 Est. Cost $11.96 Unrealized -43.5%
AVEO PHARMACEUTICALS INC 0.1%
Value ($000) $968 Shares 1,087,715 Est. Cost $1.74 Unrealized
NANOSTRING TECHNOLOGIES INC 0.1%
Value ($000) $809 Shares 40,490 Est. Cost $20.55 Unrealized
THRESHOLD PHARMACEUTICAL INC 0.1%
Value ($000) $686 Shares 1,012,255 Est. Cost $0.48 Unrealized
ONCOBIOLOGICS INC 0.1%
Value ($000) $500 Shares 416,666 Est. Cost $0.45 Unrealized
HTG MOLECULAR DIAGNOSTICS IN 0.1%
Value ($000) $472 Shares 203,464 Est. Cost $11.05 Unrealized
GENVEC INC 0.1%
Value ($000) $468 Shares 1,015,685 Est. Cost $2.63 Unrealized
NEOS THERAPEUTICS INC 0.0%
Value ($000) $333 Shares 50,613 Est. Cost $20.88 Unrealized
PVCT PROVECTUS BIOPHARMACEUTICALS 0.0%
Value ($000) $221 Shares 2,226,961 Est. Cost $0.81 Unrealized -73.1%
ONCOBIOLOGICS INC 0.0%
Value ($000) $199 Shares 416,666 Est. Cost $0.46 Unrealized
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 0.0%
Value ($000) $178 Shares 25,307 Est. Cost $18.20 Unrealized
APPLIED GENETIC TECHNOL CORP 0.0%
Value ($000) $169 Shares 17,321 Est. Cost $22.99 Unrealized
CELLECTAR BIOSCIENCES INC 0.0%
Value ($000) $145 Shares 53,649 Est. Cost $3.40 Unrealized
PROVECTUS BIOPHARMACEUTICALS 0.0%
Value ($000) $114 Shares 2,200,000 Est. Cost $0.22 Unrealized
CELLECTAR BIOSCIENCES INC 0.0%
Value ($000) $13 Shares 52,999 Est. Cost $0.55 Unrealized